Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor

Martin L. Privalsky, Sunnie M. Yoh

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Thyroid hormone receptors (T3Rs) both repress and activate gene transcription by interacting with auxiliary factors denoted corepressors and coactivators. Resistance to thyroid hormone (RTH) syndrome in humans is manifested as a failure to respond properly to elevated circulating thyroid hormone. RTH syndrome has been mapped to T3Rβ mutations that alter the transcriptional properties of the receptor, resulting in a dominant negative phenotype. We report here a characterization of a series of RTH mutant T3Rs that exhibit unusual interactions with corepressor. Two mutations in receptor helix 11 (Δ430, Δ432) greatly enhance the ability of the mutant receptors to bind to corepressor. A distinct mutation, V264D, in an 'omega loop' region of the receptor, impairs corepressor release but does not fully eliminate the ability to recruit coactivator. These mutations reveal novel determinants that regulate the interaction of the T3R with important ancillary cofactors, and that are disrupted in a human endocrine disease. (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish (US)
Pages (from-to)109-124
Number of pages16
JournalMolecular and Cellular Endocrinology
Volume159
Issue number1-2
DOIs
StatePublished - Jan 25 2000

Fingerprint

Thyroid Hormone Resistance Syndrome
Thyroid Hormone Receptors
Co-Repressor Proteins
Thyroid Hormones
Mutation
Endocrine System Diseases
Transcription
Genes
Phenotype

Keywords

  • Corepressor
  • RTH syndrome
  • SMRT
  • Thyroid hormone receptor

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor. / Privalsky, Martin L.; Yoh, Sunnie M.

In: Molecular and Cellular Endocrinology, Vol. 159, No. 1-2, 25.01.2000, p. 109-124.

Research output: Contribution to journalArticle

@article{c311a879e47849f18d70942442177319,
title = "Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor",
abstract = "Thyroid hormone receptors (T3Rs) both repress and activate gene transcription by interacting with auxiliary factors denoted corepressors and coactivators. Resistance to thyroid hormone (RTH) syndrome in humans is manifested as a failure to respond properly to elevated circulating thyroid hormone. RTH syndrome has been mapped to T3Rβ mutations that alter the transcriptional properties of the receptor, resulting in a dominant negative phenotype. We report here a characterization of a series of RTH mutant T3Rs that exhibit unusual interactions with corepressor. Two mutations in receptor helix 11 (Δ430, Δ432) greatly enhance the ability of the mutant receptors to bind to corepressor. A distinct mutation, V264D, in an 'omega loop' region of the receptor, impairs corepressor release but does not fully eliminate the ability to recruit coactivator. These mutations reveal novel determinants that regulate the interaction of the T3R with important ancillary cofactors, and that are disrupted in a human endocrine disease. (C) 2000 Elsevier Science Ireland Ltd.",
keywords = "Corepressor, RTH syndrome, SMRT, Thyroid hormone receptor",
author = "Privalsky, {Martin L.} and Yoh, {Sunnie M.}",
year = "2000",
month = "1",
day = "25",
doi = "10.1016/S0303-7207(99)00201-4",
language = "English (US)",
volume = "159",
pages = "109--124",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor

AU - Privalsky, Martin L.

AU - Yoh, Sunnie M.

PY - 2000/1/25

Y1 - 2000/1/25

N2 - Thyroid hormone receptors (T3Rs) both repress and activate gene transcription by interacting with auxiliary factors denoted corepressors and coactivators. Resistance to thyroid hormone (RTH) syndrome in humans is manifested as a failure to respond properly to elevated circulating thyroid hormone. RTH syndrome has been mapped to T3Rβ mutations that alter the transcriptional properties of the receptor, resulting in a dominant negative phenotype. We report here a characterization of a series of RTH mutant T3Rs that exhibit unusual interactions with corepressor. Two mutations in receptor helix 11 (Δ430, Δ432) greatly enhance the ability of the mutant receptors to bind to corepressor. A distinct mutation, V264D, in an 'omega loop' region of the receptor, impairs corepressor release but does not fully eliminate the ability to recruit coactivator. These mutations reveal novel determinants that regulate the interaction of the T3R with important ancillary cofactors, and that are disrupted in a human endocrine disease. (C) 2000 Elsevier Science Ireland Ltd.

AB - Thyroid hormone receptors (T3Rs) both repress and activate gene transcription by interacting with auxiliary factors denoted corepressors and coactivators. Resistance to thyroid hormone (RTH) syndrome in humans is manifested as a failure to respond properly to elevated circulating thyroid hormone. RTH syndrome has been mapped to T3Rβ mutations that alter the transcriptional properties of the receptor, resulting in a dominant negative phenotype. We report here a characterization of a series of RTH mutant T3Rs that exhibit unusual interactions with corepressor. Two mutations in receptor helix 11 (Δ430, Δ432) greatly enhance the ability of the mutant receptors to bind to corepressor. A distinct mutation, V264D, in an 'omega loop' region of the receptor, impairs corepressor release but does not fully eliminate the ability to recruit coactivator. These mutations reveal novel determinants that regulate the interaction of the T3R with important ancillary cofactors, and that are disrupted in a human endocrine disease. (C) 2000 Elsevier Science Ireland Ltd.

KW - Corepressor

KW - RTH syndrome

KW - SMRT

KW - Thyroid hormone receptor

UR - http://www.scopus.com/inward/record.url?scp=0033969578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033969578&partnerID=8YFLogxK

U2 - 10.1016/S0303-7207(99)00201-4

DO - 10.1016/S0303-7207(99)00201-4

M3 - Article

C2 - 10687857

AN - SCOPUS:0033969578

VL - 159

SP - 109

EP - 124

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -